Spanish Version of the KBILD Questionnaire

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-31

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the present study is to advance in the knowledge of quality of life in patients with ILD by translating a ILD quality of life questionnaire.

There are no specific tools validated in Spanish to evaluate the quality of life in patients with ILD, although these measures are useful for an comprensive evaluation of these patients.

Patients with ILD have a significant impact on their health. If we improve our Knowledge of the different domains affected by the disease, and not only in the pathophysiological ones, we will be able to develop tools to improve their management.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Interstitial Lung Disease Questionnaire

NCT01711151

Interstitial Lung Disease

UNKNOWN

Diagnostic Value of KL-6 in ILD

NCT03103191

Pulmonary Fibrosis

UNKNOWN

Integrating Molecular, Genomic, Morphology and Environmental Features to Improve Precision Diagnosis and Treatment in Interstitial Lung Diseases (PRECISION-ILD)

NCT05998512

Interstitial Lung Disease Interstitial Fibrosis

RECRUITING

It's Not JUST Idiopathic Pulmonary Fibrosis Study

NCT03670576

Interstitial Lung Disease Idiopathic Pulmonary Fibrosis

UNKNOWN

Validity and Reliability of the 6-Minute Pegboard and Ring Test in Interstitial Lung Disease

NCT07122141

Interstitial Lung Diseases (ILD)

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Fibrosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Quality of life questionnaire

Measurement of quality of life

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Subjects older than 18 years.
2. Diagnosis of ILD, established according to the consensus documents of the ATS and ERS \[1,2\].
3. Acceptance of the patient to participate in the study by signing the informed consent after having discussed with the researchers the objectives, risks and potential benefits.

Exclusion Criteria

1. Another chronic respiratory disease other than EPID.
2. Psychiatric disorder or limitation of collaboration (including language, socio-cultural problem, etc.).

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No